Conduit Pharmaceuticals (CDT) announces that, following confirmation of compliance with the Bid Price and Equity Requirements as detailed in the announcement dated May 21, the Company received formal notice from The Nasdaq Stock Market that the Company’s application to transfer the listing of its common stock to The Nasdaq Capital Market has been approved and the Company’s securities will be transferred to The Nasdaq Capital Market at the opening of business on May 23.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT: